Consolidated Statements of Profit or Loss
|
|
|
|
Year Ended December 31, |
||||||||||
(in thousands of $ except for shares and EPS) |
|
Note |
|
2022 |
|
2021 1) |
|
2020 1) |
||||||
Product net sales |
|
|
400,720 |
|
– |
|
– |
|||||||
Collaboration revenue |
|
|
10,026 |
|
497,277 |
|
41,243 |
|||||||
Other operating income |
|
|
34,520 |
|
42,141 |
|
23,668 |
|||||||
Total operating income |
|
|
|
445,267 |
|
539,418 |
|
64,911 |
||||||
|
|
|
|
|
|
|
|
|
||||||
Cost of sales |
|
|
|
(29,431) |
|
– |
|
– |
||||||
Research and development expenses |
|
|
(663,366) |
|
(580,520) |
|
(370,885) |
|||||||
Selling, general and administrative expenses |
|
|
(472,132) |
|
(307,644) |
|
(171,643) |
|||||||
Loss from investment in joint venture |
|
|
|
(677) |
|
– |
|
– |
||||||
Total operating expenses |
|
|
|
(1,165,607) |
|
(888,164) |
|
(542,528) |
||||||
|
|
|
|
|
|
|
|
|
||||||
Operating loss |
|
|
|
(720,341) |
|
(348,746) |
|
(477,617) |
||||||
|
|
|
|
|
|
|
|
|
||||||
Financial income |
|
|
27,665 |
|
3,633 |
|
6,459 |
|||||||
Financial expense |
|
|
(3,906) |
|
(4,578) |
|
(7,960) |
|||||||
Exchange losses |
|
|
(32,732) |
|
(50,053) |
|
(126,234) |
|||||||
|
|
|
|
|
|
|
|
|
||||||
Loss for the year before taxes |
|
|
|
(729,314) |
|
(399,743) |
|
(605,352) |
||||||
Income tax (expense)/benefit |
|
|
19,720 |
|
(8,522) |
|
(3,103) |
|||||||
Loss for the year |
|
|
|
(709,594) |
|
(408,265) |
|
(608,455) |
||||||
Loss for the year attributable to: |
|
|
|
|
|
|
|
|
||||||
Owners of the parent |
|
|
|
(709,594) |
|
(408,265) |
|
(608,455) |
||||||
Weighted average number of shares outstanding |
|
|
|
54,381,371 |
|
51,075,827 |
|
45,410,442 |
||||||
Basic and diluted loss per share (in $) |
|
|
(13.05) |
|
(7.99) |
|
(13.40) |
|||||||
|
||||||||||||||